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Abstract 
The shift towards providing high value cancer care has placed increasing importance on patient experiences. This 
scoping review summarizes patient experience literature, highlights research gaps, and provides future research 
directions. We then introduce a new resource that links the National Cancer Institute’s Surveillance Epidemiology and 
End Results (SEER) program with the Centers for Medicare and Medicaid Services Consumer Assessment of Healthcare 
Providers and Systems (CAHPS) survey and longitudinal medical claims data. We conducted a scoping review to identify 
relevant research within the Medicare CAHPS domain that examine factors associated with patient-reported experiences 
with their cancer care. Gaps indicate a need for population-based research to explore relationships between cancer 
patient experiences, healthcare utilization, and subsequent patient outcomes. SEER-CAHPS, a publicly accessible data 
resource, may assist in addressing these gaps by linking cancer registry (SEER), survey data reported by Medicare 
beneficiaries (CAHPS), and Medicare claims, providing unique insight into quality of care. Linked data include 231,089 
surveys from patients with a cancer diagnosis, and 4,236,529 surveys from patients without a cancer diagnosis. Results 
indicate substantial gaps in our knowledge of patient experiences and the need for additional resources. SEER-CAHPS 
links direct patient feedback with cancer registry and Medicare claims, making it an important source of information on 
experiences and healthcare utilization. Increasing recognition of the importance of patient-centeredness points to the 
need for population-based studies. Findings from SEER-CAHPS will inform initiatives to improve care delivery.  
 
Keywords 
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Note 
Additional information on SEER-CAHPS can be found at http://healthcaredelivery.cancer.gov/seer-cahps/ 
 
 
Introduction 
 
There are an estimated 15.5 million cancer survivors in the 
United States, and this number is projected to increase to 
almost 26.1 million by 2024, including 73% of survivors 
older than the age of 65 1. While advances in diagnostic 
and treatment capabilities have greatly increased survival 
for many cancers, increasing attention is needed on the 
experiences of cancer patients, both during and after 
treatment. The Triple Aim outlines three interdependent 
goals for improving the quality of the U.S. healthcare 
system: improving health outcomes, reducing healthcare 
costs, and improving the experience of care 2. 
 
The focus on patient experience has accompanied a shift 
in clinical practice toward a model of patient-centered 
cancer care delivery 3, 4. While there are varied definitions, 
Wolf and colleagues 3 posit that “patient experience” 
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captures a more specific measurement of patient care than 
satisfaction, and Price and colleagues 5 add that patient 
experiences can refer to any observable process, both 
subjective or objective, reflecting specific components of 
care from the patient’s perspective. Experience also 
includes the complex relationship of patient knowledge, 
values, and expectations of care. Research has noted 
several challenges in relying exclusively on patient 
satisfaction as a metric for quality, most notable that it is 
often influenced by proximal, unrelated outcomes6-8 
 
While research has indicated the importance of patient 
experience, there is a need for an in–depth examination of 
the literature to define gaps in understanding specific to 
cancer care.  While we acknowledge that there are multiple 
ways to review a scientific area, we chose to conduct a 
scoping review, which allows identification of the extent, 
nature, and range of a given research area, as well as 
existing gaps. In contrast with systematic reviews, scoping 
reviews focus more on describing a broader research area 
rather than providing a synthesis on a narrower scientific 
topic.  
 
Saunders and colleagues 9 performed a comprehensive 
review of cancer patient experience measures. While our 
scoping review is informed by this work, we chose to 
focus on core domains of patient experiences reflected in 
the Medicare CAHPS surveys, which were not included in 
the prior review. These domains include doctor/patient 
communication, coordination of care, getting needed care 
and getting care quickly (grouped as access to care for the 
current paper), quality of care/provider, quality of health 
plan, prescription drug plan customer service, and getting 
needed prescription drugs. The purpose of this study was 
to explore these key components of cancer patient 
experiences, including the identification of gaps and 
potential future research questions that could be answered 
using new data resources. We conclude with the 
introduction of a new resource that links the National 
Cancer Institute’s Surveillance Epidemiology and End 
Results (SEER) program with the Centers for Medicare 
and Medicaid Services Consumer Assessment of 
Healthcare Providers and Systems (CAHPS®) survey and 
longitudinal claims data. 
 
Approach and Methods 
 
We used the scoping methodology proposed by Arksey 
and O’Malley,10 with additional attention to 
recommendations from Levac and colleagues 11. The 6 
steps of a scoping review have been outlined as: (1) 
identify a clear research question; (2) search for relevant 
studies; (3) select studies; (4) chart the data; (5) collate, 
summarize, and report results; and (6) consult with 
stakeholders to contextualize and inform overall findings. 
Unlike systematic reviews, scoping reviews do not provide 
a standardized quality assessment of studies. Instead, 
scoping reviews typically include a summary of exemplary 
papers and identify areas for future research. 
 
We used PubMed and CINAHL to search the literature 
for studies published between 2005 and 2016, focusing on 
cancer patient experiences with care using the term cancer 
(or neoplasm) in combination with search terms found in  
Figure 1. The research team developed search terms a 
priori to reflect both core concepts cited in the patient 
experiences literature and a focus on domains included in 
the Medicare CAHPS surveys. We refined terms as needed 
using an iterative process. 
 
 
Figure 1. Search Terms Used in Combination with Cancer (Neoplasm)1 
 
Patient experience 
Satisfaction 
Communication 
Physician communication 
Patient provider communication 
Getting care quickly 
Treatment delay 
Timeliness 
Access to care 
Getting needed care 
Quality of care 
Quality 
Health plan 
Health insurance 
Prescription drug plan 
Medication 
Customer service 
 
  
1Searches were constructed using the following example logic: Search ((((((((patient experience) OR 
satisfaction) AND cancer[Title/Abstract]) AND physician communication[Title/Abstract]) OR doctor 
communication[Title/Abstract]) OR patient-provider communication[Title/Abstract]) OR patient provider 
communication[Title/Abstract]) AND full text[sb] AND ( "2001/01/01"[PDat] : "2015/07/01"[PDat] ) 
AND Humans[Mesh] AND English[lang]) Filters:Systematic Reviews; Scientific Integrity Review; Review; 
Full text; Publication date from 2001/01/01 to 2015/07/01; Humans; English. Searches were then repeated 
using the search terms listed in Figure 1. 
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Articles were included if they explored an aspect of patient 
experience as a predictor or outcome variable and/or 
included patient-reported outcomes related to experiences 
with care in one of our five targeted domains (doctor 
communication,  care coordination, access to care, patient 
perceptions of care quality, and other aspects of care, 
including prescription drug plan and customer service) In 
addition, while we recognize the distinction between 
satisfaction and experience, we chose to include studies of 
satisfaction when they focused on a specific aspect of 
patient care. Figure 2 shows the flow of articles through 
the selection process. Initial searches of the PubMed and 
CINAHL peer-reviewed literature databases resulted in 
2,046 citations. After limiting to randomized trials, 
observational studies (including quantitative, qualitative, 
and mixed-methods studies), and reviews published in 
English, 449 citations remained. 
 
A review and screening of titles and abstracts for 
adherence to inclusion criteria resulted in 48 citations. The 
vast majority were not included because they were not 
specific to cancer care. Two authors then independently 
reviewed the full text of the remaining articles, resulting in 
the exclusion of an additional 29 studies. Bibliographies of 
the articles in this subset (n=19) were then manually 
scanned to identify additional papers missed in previous 
literature searches, adding 4 studies. The inclusion of the 
final subset of 23 articles were confirmed by three authors 
to ensure adherence to inclusion criteria.  
 
Data from the final set of studies were then abstracted and 
articles were categorized based on 5 areas of interest: (1) 
doctor/patient communication, (2) care coordination, (3) 
access to care, (4) patient perceptions of care quality, and 
(5) other aspects of patient experience. When studies 
spanned more than one category, we focused on the main 
outcome as stated in the study objective. Groupings of 
these articles were confirmed by an additional reviewer. 
The following data were extracted and summarized in 
table format: objective, design and methods, primary 
outcomes, results. Descriptive summary analysis and 
qualitative thematic analysis were performed to summarize 
and report the results. We then consulted with a 
collaborative group of experts (n=15) with experience in 
 
Figure 2. Flow diagram of article selection 
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both SEER-linked data and patient experiences research to 
contextualize the findings.   
 
Results 
 
A total of 23 published articles met the inclusion criteria, 
including 1 randomized controlled trial, 11 observational 
studies, 6 reviews, and 5 qualitative or mixed methods 
studies. Table 1 summarizes the study objectives, sample 
characteristics, outcomes, and main findings for each 
included study.  
 
Patient-Provider Communication 
Four papers focused on communication between cancer 
patients and their healthcare providers: 1 review, 2 
observational, and 1 qualitative study. Important factors 
contributing to effective patient-provider communication 
include clear and timely information, emotional support, 
and opportunities for shared decision-making 12. Hack and 
colleagues 13 recorded and coded conversations between 
doctors and 172 newly diagnosed breast cancer patients, 
finding that doctors focused 88% of their communication 
on biomedical issues and that older patients and those with 
longer consultations reported the highest levels of 
satisfaction with communication.  In addition, Baile and 
colleagues 12 reported in a narrative review of patient-
provider communication in oncology that certain provider 
traits perceived by patients—friendliness, courtesy, 
empathy, and encouragement—increase patient 
satisfaction.  In analyzing survey responses from 276 lung 
cancer patients, Nelson and colleagues 14 defined 
“inadequate provider communication” as occurring when 
providers discussed 5 or more (out of 11) topics "not at 
all" or "a little bit." The topics were symptom 
management, spiritual concerns, practical needs, 
identification of a proxy, living will preparation, prognosis, 
care goals, potential complications of therapy, life support 
preferences, and hospice referral. Overall, 52% of 
respondents reported inadequate provider communication, 
and almost 90% of stage III/IV patients reported that they 
received little to no information about hospice.  Finally, a 
qualitative study by Mazor and colleagues 15 analyzed 
interviews with 137 people with cancer and their family 
members.  The authors found that patients and family 
members were most aware of and sensitive to two 
functions of communication: information exchange, 
including the domains of content, timing, sufficiency, 
clarity, and accuracy; and fostering the relationship 
between provider and patient/family, including the 
dimensions of interpersonal manner, patient commitment, 
and knowing the patient. Overall, findings from patient-
provider communication indicate that both comprehensive 
information exchange and patient provider relationship 
quality are important to patient experiences and their 
resultant health outcomes.  
 
 
Care Coordination 
Six studies identified in the review examined care 
coordination: 1 randomized trial, 2 observational studies, 1 
systematic review (n=4), and 2 qualitative/mixed-methods 
studies. Many studies included multiple cancer types 16-19, 
one focused on breast cancer 20, and another on colorectal 
cancer 21. Topics explored included perceptions of the 
critical components of care coordination 16, 18, 20 and the 
effectiveness of follow-up care delivery models, including 
nurse-led versus physician, and oncology versus primary 
care 17, 19, 21. Identified facilitators of coordinated care 
included patient navigation, effective communication 
among treatment team providers, and providing sufficient 
and timely information to patients 16, 20. Barriers reported 
as affecting a patient’s perception of care coordination 
included limited patient health literacy and obstructed 
access to the healthcare system 20. Gaps in coordination in 
both visits with and communication between primary care 
providers and oncologists could result in delays in 
appropriate treatment and follow-up care 19. In addition, 
two studies suggest that nurse-led follow-up care may be 
as effective in influencing patient experience as oncologist-
led models 17, 21.  
 
Access to Care 
Three articles (1 systematic review and 2 randomized trials, 
focusing on breast and colorectal cancers) focused on 
factors associated with patient perceptions of access to 
care, including getting needed care, surveillance adherence, 
and timeliness of care receipt 22-24. A prospective 
randomized trial assessing patient satisfaction with 
telephone follow-up versus hospital follow-up visits 
revealed no differences between the two modalities; 
however, scores for access to care items (getting care 
quickly, timeliness of care, and quality of care) were higher 
among patients receiving telephone follow-up calls vs. 
hospital follow-up 24. Hendren and colleagues 23 found 
that racial and ethnic minority breast and colorectal cancer 
patients experience a higher number of social and 
instrumental barriers to receipt of care, ranging from 
communication to transportation, according to a study 
examining barriers to receiving care. Finally, a systematic 
review of 34 studies conducted by Carpentier and 
colleagues 22 assessing receipt of recommended 
surveillance and correlates of adherence among colorectal 
cancer survivors found large variation of both under and 
over utilization of recommended follow up care. The 
authors found that the majority of studies examined 
sociodemographic and disease/treatment factors, failing to 
investigate modifiable factors (i.e. system-level, patient 
experiences, psychosocial factors) and their influence on 
adherence to surveillance.   
 
Patient Perceptions of Care Quality 
Health Plan Quality: Nine papers that focused on patient 
perceptions of care quality were included in the review, 
including 5 observational studies and 4 literature reviews. 
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One notable study focused on associations between 
perceptions of care quality and survival for colorectal 
cancer patients 25, and found that patients reporting they 
were “completely satisfied” with their care demonstrated a 
significantly lower mortality, after controlling for clinical 
and sociodemographic characteristics. Four focused on 
quality of the health plan 26-29, and all investigated the 
variability of patient quality ratings across Medicare 
Advantage (MA) plans and subsequent impact on initial 
patient enrollment and changes in enrollment.  A 2006 
study assessed variations in care quality (based on 
Healthcare Effectiveness Data and Information Set 
(HEDIS) measures) across racial/ethnic groups, and 
determined that only 1 plan out of 151 assessed achieved 
both high quality and low disparity on more than 1 
measure 26. Another more recent study 28 examined 
associations between MA star ratings and plan enrollment 
and determined that an increase of 1 star was associated 
with 9.5% increase in likelihood to enroll. The authors also 
found that star ratings were less strongly associated with 
enrollment for black, rural, low-income, and younger 
beneficiaries. Xu and colleagues 29 investigated whether 
MA contract characteristics are associated with quality of 
care through star ratings and determined that nonprofit 
(vs. for-profit), larger, and older MA contracts were more 
likely to receive higher star ratings. An additional study 
assessed associations between MA plan attributes (cost, 
quality, and benefits) and beneficiary enrollment, finding 
that preference for higher quality and lower-cost MA plans 
with diminishing differences at higher star ratings of 4 and 
5 27. 
 
Healthcare Provider Quality: A systematic review of 11 
studies of patient perceptions of healthcare providers 
(specifically physicians) identified the constructs of loyalty, 
personal care, trust, and continuity as important guiding 
principles for assessing patient perceptions of provider 
quality. This review pointed toward the need for 
longitudinal research to further characterize the important 
attributes of patient-provider relationships. 30. An 
additional systematic review of 44 studies of 
provider/institution-level factors and outcomes in ovarian 
cancer patients concluded that discipline and sub-
specialization of primary treating physician conferred the 
biggest impact on survival and suggested improving trends 
in patient experience over time 31.  
 
End-of-life Care Quality: Two papers focused on quality 
of end-of-life care are noteworthy. One study conducted 
within the Veteran’s Health Administration determined 
key areas of quality that should be assessed: addressing 
patient well-being and dignity, providing adequate health 
information and communication; providing emotional and 
spiritual support; providing care around time of death, 
availing access to supportive services before the death, and 
providing access to benefits and services after the patient's 
death  32. Finally, a narrative review identified referral to 
hospice within the last few days of life as a potential 
indicator of patient-perceived poor quality care 33.   
 
Other Aspects of Patient Experience including 
Prescription Drug Plan and Customer Service 
Our review did not identify studies exploring potential 
additional drivers of patient experience, such as healthcare 
customer service. One cross-sectional study did explore 
potential drivers of older adult patients’ experience with 
prescription drug plans 34, looking at associations between 
the practice of prescribing and utilization of high risk 
medications and Medicare Part D CMS star ratings for 
composites including “Getting Needed Prescription 
Drugs,” “Complaints about Drug Plan,” “Rating of Drug 
Plan,” and “Members Choosing to Leave the Plan.” 
Medicare Star Ratings assess the performance of 
contracted health and drug plans on indicators of care 
access, clinical quality, member satisfaction, and customer 
service. Erickson and colleagues observed weak but 
significant associations between high-risk medications and 
“Getting Prescription Drugs,” suggesting that high-risk 
medication usage is likely only one of many factors 
influencing overall member experience. The authors 
suggest that members may also place importance on 
perceived cost burdens when rating their prescription drug 
plans. It is also important to note that this study did not 
test for associations with actual utilization of prescription 
drug plans and subsequent health outcomes, a potential 
area for future research.  
 
Summary and Implications from Scoping Review 
 
We conducted this scoping review to identify gaps in the 
literature exploring specific factors related to patient 
experience in cancer care. Although a considerable amount 
of research has been done on patient experience, our 
review identified several important areas for future 
research. In general, there were few studies focusing on 
the associations between experience and outcomes 
including healthcare utilization, cost, adherence to 
guideline-concordant care, and patient health outcomes. 
As reimbursement models shift from pay for volume to 
pay for performance, there is increasing recognition of the 
importance of incorporating patient experiences in the 
definition of value 35. It is essential to connect patient 
experiences with such outcomes to comprehensively 
define value.  
 
Our analysis pointed to several important areas for future 
research, particularly in the areas of care coordination, 
patient-provider communication, and access to care. While 
the importance of effective patient-provider 
communication in cancer care is well-documented 36, our 
analysis indicated gaps in exploring drivers of cancer 
patient experiences with communication. In addition, 
future research could focus on the effects of 
communication on patient behaviors, and relationships 
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between provider engagement, time spent, and patient 
behaviors.  
 
There were few studies capturing cancer patient 
experiences with care coordination, particularly between 
oncologists and primary care providers, and specifically in 
medically underserved and rural patients. With an 
increasingly limited and overworked physician taskforce 37, 
38, coordination between multiple types of healthcare 
providers, including midlevel providers, both during 
treatment and into survivorship is essential. Future 
research should focus on exploring the relationship 
between patient experiences with coordination and patient 
adherence to treatment, access, and cost of care. There is 
also great potential to explore patient experiences with 
models of follow-up care, as well as communication 
between providers.   
 
Much of the previously published literature on perceived 
access to care focuses on access to follow-up after 
abnormal diagnostic results and subsequent survival. Gaps 
remain in our understanding of relationships between a 
patient’s perceptions of access to care and adherence to 
cancer treatment and surveillance for recurrence and 
secondary cancers. Access to care has implications at all 
phases of the cancer care continuum, impacting outcomes 
from screening to diagnosis and treatment39. Further 
research is necessary to define the effect of access beyond 
initial treatment, including survivorship and palliative care. 
Our review also indicates a need for longitudinal research 
to further characterize the effects of patient-provider 
relationships on the quality of healthcare. Patients, 
particularly older adults, are being offered a growing 
number of healthcare plan choices, which further increases 
the importance for patient-perceived quality reporting and 
evaluation 40. It is thus essential to investigate the effect of 
quality ratings on healthcare utilization. The role of health 
plan and care quality for underserved and vulnerable 
cancer patients also warrants further investigation.  
 
 Finally, there were few studies on other important aspects 
of patient experience, including healthcare customer 
service. Patients often face difficulties in completing 
paperwork and managing the administrative aspects of 
their care, including challenges in reaching their providers 
by telephone, unresponsiveness of office staff, and an 
increasing number of forms to fill out. These barriers can 
deter subsequent care-seeking and affect outcomes such as 
adherence to treatment and symptom reporting. We found 
no studies examining cancer patient experiences with 
provider and health plan customer service nor its relation 
to adherence through treatment and survivorship.   
 
The results reported here are subject to certain limitations. 
First, the emphasis of the scoping review on concepts 
assessed by the CAHPS survey necessarily resulted in the 
exclusion of large subsets of the patient experience 
literature. In addition, this scoping review was limited to 
studies published in English since 2005, and focused on 
studies in North America.  
 
New Research Resource to Examine Cancer 
Patient Experiences with Care: SEER-CAHPS 
 
Overall, our review indicated that data resources are 
needed to explore both drivers and outcomes of patient 
experiences with cancer care. SEER-CAHPS is one such 
resource that could provide a great deal of information in 
each of these areas. The SEER-CAHPS linkage has been 
previously described by Chawla and colleagues 41. We now 
present an updated report of the data resource and 
descriptive analyses, following the most recent linkage 
completed in 2015. Four principle data sources comprise 
the linked dataset: 1) CAHPS data for all Medicare 
Advantage (MA) and Fee for Service (FFS) beneficiaries 
between 1997 and 2013; 2) SEER data for CAHPS survey 
respondents with cancer living in a SEER-designated 
region and diagnosed between 1973-2011; 3) Medicare 
Enrollment Database demographic and eligibility data for 
all CAHPS survey respondents (1973-2011); and 4) 
Medicare claims data for all FFS beneficiaries who were 
CAHPS survey respondents (2002-2013). It is important to 
note that Medicare claims for 2002-2004 are only available 
for those who answered a survey in 2011 or prior.  
Medicare CAHPS survey items and composites can be 
used in research as both predictor and outcome variables 
in studies of patient experience among older adults with 
cancer. Linking CAHPS survey responses with SEER data 
and Medicare claims makes it possible to answer complex 
questions beyond traditional unlinked survey data. SEER-
CAHPS has the potential to inform providers and 
consumers in several health topic areas, and Table 2 details 
potential future research questions in each domain.  
 
Most importantly, this data resource provides a rich 
opportunity for analyses of Medicare beneficiaries’ 
experiences with their care at various stages of the cancer 
care continuum, including: the initial year after diagnosis, 
when patients are most likely to receive cancer treatments; 
the years of immediate post-treatment follow-up care; 
those of long-term cancer survivorship; and the final end-
of-life care phase. Table 3 shows demographic 
characteristics of CAHPS respondents residing in SEER 
areas from 1998-2013, and Table 4a and 4b indicate 
number of linked participants by time between first survey 
and diagnosis by cancer type for MA (2a) and FFS (2b) 
respondents, respectively, focusing on the most prevalent 
cancer types in the SEER-CAHPS linkage. It is important 
to note that the number of surveys is not equivalent to the 
number of individual beneficiaries, as approximately 10% 
of respondents were sent and answered the survey 
multiple times. For those with multiple surveys, only the 
first survey is analyzed. The most prevalent cancer types 
are prostate, breast, colorectal, and lung/bronchial. In 
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total, the analytic file contains data from 4,467,618 
Medicare beneficiaries, representing 231,089 surveys from 
patients with a cancer diagnosis, and 4,236,529 surveys 
from patients without a cancer diagnosis. 
 
Although SEER-CAHPS can provide important insights 
into the experiences of care for patients with cancer, some 
limitations do exist. The data are limited to SEER registry 
areas, which represent approximately 30% of cancer cases 
in the U.S. ( http://seer.cancer.gov/data/), as well as 
Medicare beneficiaries, including those over age 65 or 
eligible due to disability. Although some individuals have 
completed more than one survey, the linked resource was 
not designed for, and is not well-suited for, longitudinal 
survey analysis. As claims data are only available for FFS 
beneficiaries, sample size for analyses wishing to 
incorporate claims may be limited depending on cancer 
type. There is an adequate sample size for many types, 
however, as shown in Tables 4a and 4b. In addition, we 
acknowledge that data resources are not the only method 
to explore patient experiences. This resource, however, has 
a unique ability to answer questions using a population-
based sample. Overall, SEER-CAHPS is a comprehensive 
source of information that provides the opportunity to 
link patient experiences with healthcare outcomes and 
compare individuals with and without cancer.  
 
Summary 
 
With increasing numbers of older adults living with cancer, 
receiving complex treatments, and dealing with complex 
and fragmented healthcare systems, studies of cancer 
patients’ experiences are timely and imperative. This 
scoping review has highlighted key areas for future 
research on patient experiences, including key research 
questions that can be answered using a new linked data 
resource. SEER-CAHPS is a unique resource that can be 
used to understand cancer care delivery and the impact on 
patient outcomes at all phases of the cancer care trajectory. 
It also has the potential to assist healthcare systems and 
policy makers in improving the quality of care for 
Medicare beneficiaries with cancer.   
 
References 
 
1. Bluethmann, S.M., A.B. Mariotto, and J.H. 
Rowland, Anticipating the "Silver Tsunami": 
Prevalence trajectories and comorbidity burden among 
older cancer survivors in the United States. Cancer 
Epidemiology Biomarkers and Prevention, 2016. 
25(7): p. 1029-1036. 
2. Berwick, D.M., T.W. Nolan, and J. Whittington, 
The triple aim: Care, health, and cost. Health Affairs, 
2008. 27(3): p. 759-769. 
3. Wolf, J.A., et al., Defining patient experience. Patient 
Experience Journal, 2014. 1(1): p. 7-19. 
4. Lines, L.M., M. Lepore, and J.M. Wiener, Patient-
centered, person-centered, and person-directed care: They 
are not the same. Medical Care, 2015. 53(7): p. 561-
563. 
5. Price, A., et al., Examining the role of patient 
experience surveys in measuring health care quality. 
Medical Care Research and Review, 2014. 71(5): 
p. 522-554. 
6. Arneill, A. and A. Devlin, Perceived quality of care. 
The influence of the waiting room environment. Journal 
of Environmental Psychology, 2002. 22(4): p. 
345-360. 
7. Deitrick, L., et al., Becoming a leader in patient 
satisfaction: Changing the culture of care in an academic 
community hospital. Health Mark 2006. 23(3): p. 31-
57. 
8. Anderson, R., A. Barbara, and S. Feldman, What 
patients want: A content analysis of key qualities that 
influence patient satisfaction. Journal of Medical 
Practice Management, 2007. 22(5): p. 255-261. 
9. Saunders, C., et al., Cancer patient experience 
measures: An evidence review. Journal of 
Psychosocial Oncology, 2016 p. 1-23. 
10. Arksey, H. and L. O'Malley, Scoping studies: 
Towards a methodological framework. International 
Journal of Social Research Methodology, 2005: p. 
19-32. 
11. Levac, D., H. Colquhoun, and K. O'Brien, 
Scoping studies: Advancing the methodology. 
Implementation Science, 2010. 5(69): p. 1-9. 
12. Baile, W.F. and J. Aaron, Patient-physician 
communication in oncology: past, present, and future. 
Curr Opin Oncol, 2005. 17(4): p. 331-5. 
13. Hack, T.F., et al., Behind closed doors: systematic 
analysis of breast cancer consultation communication and 
predictors of satisfaction with communication. 
Psychooncology, 2010. 19(6): p. 626-36. 
14. Nelson, J.E., et al., Patients rate physician 
communication about lung cancer. Cancer, 2011. 
117(22): p. 5212-20. 
15. Mazor, K.M., et al., Patients' and family members' 
views on patient-centered communication during cancer 
care. Psychooncology, 2013. 22(11): p. 2487-95. 
16. Walsh, J., et al., What is important in cancer care 
coordination? A qualitative investigation. Eur J Cancer 
Care (Engl), 2011. 20(2): p. 220-7. 
17. Lewis, R., et al., Nurse-led vs. conventional physician-
led follow-up for patients with cancer: systematic review. J 
Adv Nurs, 2009. 65(4): p. 706-23. 
18. Arora, N.K., et al., Assessment of quality of cancer-
related follow-up care from the cancer survivor's 
perspective. J Clin Oncol, 2011. 29(10): p. 1280-9. 
Patient experiences of cancer care, Mollica et al. 
110  Patient Experience Journal, Volume 4, Issue 1 – Spring 2017 
19. Shen, M.J., et al., A mixed-methods examination of 
communication between oncologists and primary care 
providers among primary care physicians in underserved 
communities. Cancer, 2015. 121(6): p. 908-15. 
20. Hawley, S.T., et al., Perceptions of care coordination in 
a population-based sample of diverse breast cancer 
patients. Patient Educ Couns, 2010. 81 Suppl: p. 
S34-40. 
21. Young, J.M., et al., Multicenter randomized trial of 
centralized nurse-led telephone-based care coordination to 
improve outcomes after surgical resection for colorectal 
cancer: the CONNECT intervention. J Clin Oncol, 
2013. 31(28): p. 3585-91. 
22. Carpentier, M.Y., et al., Receipt of recommended 
surveillance among colorectal cancer survivors: a systematic 
review. J Cancer Surviv, 2013. 7(3): p. 464-83. 
23. Hendren, S., et al., Patients' barriers to receipt of 
cancer care, and factors associated with needing more 
assistance from a patient navigator. J Natl Med Assoc, 
2011. 103(8): p. 701-10. 
24. Kimman, M.L., et al., Patient satisfaction with nurse-
led telephone follow-up after curative treatment for breast 
cancer. BMC Cancer, 2010. 10: p. 174. 
25. Gupta, D., C.G. Lis, and M. Rodeghier, Can 
patient experience with service quality predict survival in 
colorectal cancer? Journal for Healthcare Quality, 
2013. 35(6): p. 37-43. 
26. Trivedi, A.N., et al., Relationship between quality of 
care and racial disparities in Medicare health plans. 
JAMA, 2006. 296(16): p. 1998-2004. 
27. Reid, R.O., et al., The Roles of Cost and Quality 
Information in Medicare Advantage Plan Enrollment 
Decisions: an Observational Study. J Gen Intern Med, 
2015. 
28. Reid, R.O., et al., Association between Medicare 
Advantage plan star ratings and enrollment. JAMA, 
2013. 309(3): p. 267-74. 
29. Xu, P., et al., Relationships between Medicare 
Advantage contract characteristics and quality-of-care 
ratings: an observational analysis of Medicare Advantage 
star ratings. Ann Intern Med, 2015. 162(5): p. 353-
8. 
30. Ridd, M., et al., The patient-doctor relationship: a 
synthesis of the qualitative literature on patients' 
perspectives. Br J Gen Pract, 2009. 59(561): p. 
e116-33. 
31. du Bois, A., et al., Variations in institutional 
infrastructure, physician specialization and experience, 
and outcome in ovarian cancer: a systematic review. 
Gynecol Oncol, 2009. 112(2): p. 422-36. 
32. Finlay, E., S. Shreve, and D. Casarett, Nationwide 
veterans affairs quality measure for cancer: the family 
assessment of treatment at end of life. J Clin Oncol, 
2008. 26(23): p. 3838-44. 
33. Earle, C.C., et al., Aggressiveness of cancer care near 
the end of life: is it a quality-of-care issue? J Clin Oncol, 
2008. 26(23): p. 3860-6. 
34. Erickson, S.C., R.S. Leslie, and B.V. Patel, Is there 
an association between the high-risk medication star 
ratings and member experience CMS star ratings 
measures? J Manag Care Spec Pharm, 2014. 
20(11): p. 1129-36. 
35. Porter, M., What is value in health care. New Englan 
Journal of Medicine, 2010. 363(26): p. 2477-
2481. 
36. Epstein, R.M. and R.L. Street, Jr., Patient-centered 
communication in cancer care: Promoting healing and 
reducing suffering. Vol. 07-6225. 2007, Bethesda, 
MD: National Cancer Institute. 
37. Petterson, S.M., et al., Projecting US primary care 
physician workforce needs: 2010-2025. Annals of 
Family Medicine, 2012. 10: p. 503-509. 
38. Yang, W., et al., Projected supply of and demand for 
oncologists and radiation oncologists through 2025: An 
aging, better-insured population will result in shortage. 
Journal of Oncology Practice, 2014. 10(1): p. 39-
45. 
39. Zapka, J., et al., Multilevel factors affecting quality: 
Examples from the cancer care continuum. Journal of 
the National Cancer Institute Monographs, 2012. 
44: p. 11-19. 
40. Faber, M.J., et al., Public reporting in health care: How 
do consumers use quality-of-care information? A 
systematic review. Medical Care, 2009. 47(1): p. 1-8. 
41. Chawla, N., et al., Unveiling SEER-CAHPS: A 
new data resource for quality of care research. Journal of 
General Internal Medicine, 2015. 30(5): p. 641-
650. 
 
 
 
 
 
 
 
 
 
 
 
Patient experiences of cancer care, Mollica et al. 
 
111  Patient Experience Journal, Volume 4, Issue 1 – Spring 2017 
 
Table 1. Study characteristics and outcomes 
 
Citation Objective Design and Methods Primary Outcomes Results 
Patient-Provider 
Communication 
        
Baile, W.F. and J. Aaron, 
Patient-physician 
communication in oncology: 
past, present, and future. 
Curr Opin Oncol, 2005. 17(4): 
p. 331-5. 
Highlight relevant studies on 
outcomes of communication 
with the cancer patient; 
discuss implications for 
training oncologists 
Narrative Review Measuring communication, 
foundation and benefits of 
communication, gaps in 
communication, barriers to 
effective communication, 
communicating change in 
prognosis, empowering 
patients, teaching and 
learning communication skills 
Effective communication 
with cancer patient and 
family can influence desirable 
outcomes (including quality 
of life, satisfaction with care, 
and medical outcomes) 
Hack, T.F., et al., Behind 
closed doors: systematic 
analysis of breast cancer 
consultation communication 
and predictors of satisfaction 
with communication. 
Psychooncology, 2010. 19(6): 
p. 626-36. 
Explicate content of primary 
adjuvant treatment 
consultations in breast 
oncology, examine predictive 
relationships between patient 
and oncologist consultation 
factors and patient 
satisfaction with 
communication 
Secondary descriptive study 
of women with breast cancer 
presenting for primary 
adjuvant treatment 
consultation who previously 
participated in prior 
communication  
Coding of audiotapes using 
the Medical Interaction 
Processing System (MIPS); 
patient satisfaction with 
communication using Patient 
Perception Scale-assessing 
degree to which patient feels 
oncologist has adequately 
addressed the patient's 
disease concerns and been 
patient-focused during 
consultation 
Biomedical content 
categories predominant in the 
consultations (88%), 
followed by administrative 
and psychosocial utterances; 
post-consultation satisfaction 
with communication was 
significantly higher for older 
patients, those with smaller 
primary tumors and those 
with longer consultation 
Mazor, K.M., et al., Patients' 
and family members' views 
on patient-centered 
communication during 
cancer care. Psychooncology, 
2013. 22(11): p. 2487-95. 
Explore patients' and family 
members' views of 
communication during 
cancer care and identify 
aspects of patient-provider 
communication most 
important to patients and 
family members 
Secondary data analysis of 
qualitative data of 137 
patients with cancer and 
family members  
qualitative (NA) Patients want clinicians who 
provide information they 
need, when they need it, in a 
way they can understand; 
want physicians to listen and 
respond to questions and 
concerns; failure to provide 
information a patient needs 
could damage relationship 
and were integral to decision 
making, managing 
uncertainty 
Patient experiences of cancer care, Mollica et al. 
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Nelson, J.E., et al., Patients 
rate physician 
communication about lung 
cancer. Cancer, 2011. 117(22): 
p. 5212-20. 
Evaluate communication 
with lung cancer patients 
Descriptive study of 276 lung 
cancer patients 
Patient reported rating of 
physician communication on 
symptoms, spiritual concerns, 
practical needs, proxy 
appointment, living will prep, 
prognosis, care goals, 
potential complications of 
therapy, life support 
preferences, and hospice 
Majority reported that 
physicians communicated not 
at all or a little bit, low ratings 
frequent for discussion of 
emotional symptoms, 
practical needs, spiritual 
concerns, proxy 
appointment, living will prep, 
life support preferences, and 
hospice; communication 
inadequate for patients of 
different ages, stages, and 
races 
Care Coordination         
Arora, N.K., et al., 
Assessment of quality of 
cancer-related follow-up care 
from the cancer survivor's 
perspective. J Clin Oncol, 
2011. 29(10): p. 1280-9. 
Assess survivors' perceptions 
of different aspects of care in 
the last 12 months 
Observational survey of 623 
leukemia, bladder, colorectal 
cancer survivors diagnosed 2 
to 5 years prior 
Perceptions of different 
aspects of care, overall 
ratings of care 
Delivery of quality follow-up 
care to cancer survivors may 
require efforts to improve 
patient-centered 
communication and 
coordination. Special 
emphasis needed on health 
promotion discussions and 
adoption of holistic care 
Hawley, S., Janz, N., Lillie, S. 
et al. (2010). Perceptions of 
care coordination in a 
population-based sample of 
diverse breast cancer 
patients. Patient Education 
and Counseling (81), Suppl: 
S34-40.  
Identify factors associated 
with perceptions of care 
coordination in diverse 
sample of breast cancer 
patients 
Survey of 2268 breast cancer 
patients from SEER 
registries post diagnosis  
Patient appraisal of care 
coordination during 
treatment experience; factors 
associated with care 
coordination 
16.4% of women perceived 
low care coordination; 12.5% 
reported low satisfaction; 
race/ethnicity not 
significantly associated with 
care coordination; women 
with low health literacy 3-4 
times likely to perceive low 
care coordination and low 
satisfaction with care 
coordination 
Lewis, R., et al., Nurse-led 
vs. conventional physician-
led follow-up for patients 
with cancer: systematic 
review. J Adv Nurs, 2009. 
65(4): p. 706-23. 
Evaluate effectiveness and 
cost-effectiveness of nurse-
led follow-up for patients 
with cancer 
Systematic review of (n=4) 
comparative studies and 
economic evaluations of 
nurse-led vs physician-led 
follow-up studies 
Survival, recurrence, 
psychological morbidity; 
patient satisfaction, cost 
Patients satisfied with nurse-
led follow up; could consider 
patient-initiated or telephone 
follow-up to conventional 
care; more research needed 
Patient experiences of cancer care, Mollica et al. 
 
 
113  Patient Experience Journal, Volume 4, Issue 1 – Spring 2017 
 
Shen, M.J., et al., A mixed-
methods examination of 
communication between 
oncologists and primary care 
providers among primary 
care physicians in 
underserved communities. 
Cancer, 2015. 121(6): p. 908-
15. 
Explore PCP perceptions of 
communication with 
oncologists as well as PCP 
communication needs 
Mixed methods-qualitative 
phase, interviewed 18 
primary care providers 
practicing in underserved, 
minority communities; 
quantitative phase, online 
survey of 129 providers 
about preferences, 
experiences, and satisfaction 
with communication with 
oncologists 
Qualitative: experiences with 
oncologists  
Quantitative: survey with 
questions on post-referral 
communication practices 
with oncologists; attitudes 
toward and preference for 
communication with 
oncologists 
PCP-oncologist gap in 
communication occurred 
between diagnosis and 
treatment; PCPs wanted 
more communication with 
oncologists; wanted updates 
on patients' prognosis 
throughout treatment, and to 
be contacted via telephone or 
email 
Walsh, J., et al., What is 
important in cancer care 
coordination? A qualitative 
investigation. Eur J Cancer 
Care (Engl), 2011. 20(2): p. 
220-7. 
Explore views and 
experiences of key 
stakeholders to identify the 
key components of cancer 
care coordination 
Explorative descriptive 
qualitative study of 20 Cancer 
patients, 4 caregivers, 29 
clinicians 
Key components of care 
coordination in cancer 
Organization of patient care, 
access to and navigation 
through healthcare system, 
allocation of 'key' contact 
person, effective 
communication and 
cooperation among 
multidisciplinary team and 
providers, delivery of services 
in complementary and timely 
manner 
Young, J.M., et al., 
Multicenter randomized trial 
of centralized nurse-led 
telephone-based care 
coordination to improve 
outcomes after surgical 
resection for colorectal 
cancer: the CONNECT 
intervention. J Clin Oncol, 
2013. 31(28): p. 3585-91. 
Investigate effectiveness of a 
centralized, nurse-delivered 
telephone based service to 
improve care coordination 
and patient reported 
outcomes post colorectal 
cancer surgery 
Two-arm parallel-group 
randomized trial of 756 
patients undergoing surgery 
for primary colorectal cancer 
FACT-C and Distress 
thermometer, questions 
about postop health services 
utilization; care coordination; 
Supportive Care Needs 
Survey Short Form, 
measuring unmet needs in 
domains: psychological, 
health system and info, 
physical and daily living, 
patient care and support, 
sexuality 
 
 
 
 
Nurse-led follow-up may be 
as effective as oncologist in 
meeting patient needs; 
increases access 
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Access         
Carpentier, M.Y., et al., 
Receipt of recommended 
surveillance among colorectal 
cancer survivors: a systematic 
review. J Cancer Surviv, 2013. 
7(3): p. 464-83. 
Examine receipt of 
recommended post-
treatment surveillance tests 
and procedures among CRC 
survivors, including 
adherence to established 
guidelines; identify correlates 
of CRC surveillance 
Systematic review of 34 
studies 
Adherence, socio-
demographic factors, 
patterns of association with 
adherence 
Surveillance focused mainly 
on patient socio-demographic 
factors and disease/treatment 
characteristics; need for 
future work focusing on 
system- and provider-level 
issues, including patient 
experience, access to care, 
and care coordination among 
members of the oncology 
and PCP  
Hendren, S., et al., Patients' 
barriers to receipt of cancer 
care, and factors associated 
with needing more assistance 
from a patient navigator. J 
Natl Med Assoc, 2011. 103(8): 
p. 701-10. 
Understand patients' barriers 
to cancer care; determine 
which patients have a greater 
need for assistance from a 
patient navigator 
Survey during randomized 
trial of 103 newly-diagnosed 
breast and colorectal cancer 
patients 
Patient-reported barriers of 
care 
Lack of social support, 
insurance/financial concerns, 
and problems communicating 
with health care providers. 
Barriers differed between 
non-minority and minority 
patients, and minority 
patients faced a greater 
number of barriers 
Kimman, M.L., et al., Patient 
satisfaction with nurse-led 
telephone follow-up after 
curative treatment for breast 
cancer. BMC Cancer, 2010. 
10: p. 174. 
Explore patient satisfaction; 
investigate cost-effectiveness 
of several follow-up 
strategies in first year after 
breast cancer treatment 
Patient satisfaction among 
299 breast cancer patients 
post treatment who were 
participants of RCT  
Ware's Patient Satisfaction 
Questionnaire (PSQ III) 
Nurse-led telephone follow-
up care significantly higher 
for patient satisfaction with 
access to care. Nurse-led 
follow-up care may be 
acceptable alternative to 
traditional hospital follow-up 
Quality of Care         
du Bois, A., et al., Variations 
in institutional infrastructure, 
physician specialization and 
experience, and outcome in 
ovarian cancer: a systematic 
review. Gynecol Oncol, 2009. 
112(2): p. 422-36. 
Summarize available data 
evaluating impact of different 
physician and hospital 
characteristics on outcomes 
in ovarian cancer patients 
Systematic review 44 studies 
assessing relationship 
between physician and/or 
hospital specialty or volume 
and at least one outcome of 
interest 
Survival (Surgical outcome, 
completeness of staging, 
patient experience) 
Discipline and sub-
specialization of primary 
treating physician most 
important for survival; 
showed some improvement 
in patient experience over 
time 
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Earle, C.C., et al., 
Aggressiveness of cancer care 
near the end of life: is it a 
quality-of-care issue? J Clin 
Oncol, 2008. 26(23): p. 3860-6. 
Review literature and update 
analyses to the aggressiveness 
of cancer care near the end 
of life 
Narrative review Trends and predictors of 
aggressive cancer care 
(chemo near death and 
underutilization of hospice 
services) 
High proportion of patients 
never referred to hospice, or 
referred only in last few days 
of life may indicate poor-
quality care 
Finlay, E., S. Shreve, and D. 
Casarett, Nationwide 
Veterans Affairs quality 
measure for cancer: the 
family assessment of 
treatment at end of life. J Clin 
Oncol, 2008. 26(23): p. 3838-
44. 
Describe national initiative to 
measure quality of care at 
end of life (FATE-Family 
assessment of treatment at 
end of life) 
Descriptive study of quality 
initiative with surrogates for 
262 deceased cancer patients  
FATE: reflects key areas of 
palliative care-patient's well-
being and dignity, adequacy 
of information and 
communication, emotional 
and spiritual support, care 
around time of death, access 
to services before the death, 
access to benefits and 
services after the patient's 
death 
Higher satisfaction of care 
associated with palliative care 
consultation, hospice referral, 
and having a DNR at time of 
death. Lower satisfaction 
scores associated with ICU 
death 
Reid, R.O., et al., Association 
between Medicare Advantage 
plan star ratings and 
enrollment. JAMA, 2013. 
309(3): p. 267-74. 
Assess association between 
Medicare Advantage plan 
quality ratings and 
enrollment 
Cross-sectional study of 2011 
Medicare Advantage (MA) 
enrollments among 952,352 
first-time enrollees and 
322,699 enrollees switching 
plans 
Likelihood to enroll and star 
ratings 
1-star higher rating associated 
with 9.5 percentage-point 
increase in likelihood to 
enroll; highest rating 
associated with 1.9 
percentage point increase in 
likelihood to enroll; star 
ratings less strongly 
associated with enrollment 
for black, rural, low-income, 
and youngest beneficiaries 
Reid, R.O., et al., The Roles 
of Cost and Quality 
Information in Medicare 
Advantage Plan Enrollment 
Decisions: An Observational 
Study. J Gen Intern Med, 
2015. 
Assess associations between 
MA plan attributes (cost, 
quality, and benefits), brand 
market share, and 
beneficiary’s enrollment 
decisions 
Cross-sectional study of 
84,7069 beneficiaries 
enrolling in Medicare 
Advantage for the first time 
in 2011 
Plan attributes and 
enrollment; willingness to pay 
for quality 
Beneficiaries prefer higher 
quality and lower-cost MA 
plans, but marginal utility for 
quality diminishes at higher 
star ratings 
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Ridd, M., et al., The patient-
doctor relationship: a 
synthesis of the qualitative 
literature on patients' 
perspectives. Br J Gen Pract, 
2009. 59(561): p. e116-33. 
Derive conceptual 
framework of factors that 
define patient-doctor 
relationships from patient 
perspective 
Systematic review and 
synthesis of qualitative 
literature of 11 studies 
Patient-doctor relationship 
aspects 
Studies explored patient-
doctor relationship generally, 
or specifically in loyalty, 
personal care, trust, and 
continuity; longitudinal care 
and patient experiences 
important; future research 
needed on associations 
between longitudinal care, 
patient experiences, and 
depth of patient-provider 
relationship 
Trivedi, A.N., et al., 
Relationship between quality 
of care and racial disparities 
in Medicare health plans. 
JAMA, 2006. 296(16): p. 1998-
2004. 
Assess variations among 
Medicare health plans in 
overall quality and racial 
disparity in HEDIS 
measures, to determine 
whether high-performing 
plans exhibit smaller racial 
disparities; identify plans with 
high quality and low disparity 
Analysis of 43,1573 
observations in 151 Medicare 
health plans from 2002 to 
2004; regression of 
relationship between quality 
and racial disparity 
Hemoglobin A1C for 
enrollees with diabetes; blood 
pressure for those with 
HTN, cholesterol level for 
enrollees with diabetes post 
coronary event 
Clinical performance on 
HEDIS measures lower for 
Black enrollees than White; 
health plans varied 
substantially in overall quality 
and racial disparity on each of 
the 4 outcome measures; only 
1 health plan achieved both 
high quality and low disparity 
on more than 1 measure 
Xu, P., et al., Relationships 
between Medicare Advantage 
contract characteristics and 
quality-of-care ratings: an 
observational analysis of 
Medicare Advantage star 
ratings. Ann Intern Med, 
2015. 162(5): p. 353-8. 
Investigate whether MA 
contract characteristics are 
associated with quality of 
care through Medicare star 
ratings 
Retrospective study of MA 
star ratings in 2010 on 409 
Medicare Advantage 
contracts 
Star ratings, plan 
characteristics (contract 
enrollment numbers, contract 
maturity, contract type, 
operating area) 
Nonprofit, larger, and older 
MA contracts more likely to 
receive higher star ratings; 
nonprofit MA contracts 
received significantly higher 
star ratings than for-profit 
contracts 
Other Aspects         
Erickson, S.C., R.S. Leslie, 
and B.V. Patel, Is there an 
association between the high-
risk medication star ratings 
and member experience CMS 
star ratings measures? J 
Manag Care Spec Pharm, 
2014. 20(11): p. 1129-36. 
Determine if high-risk 
medication star ratings are 
associated with member 
experience CMS star ratings 
Cross-sectional analysis of 
443 Medicare contracts for 
MA-prescription drug plan 
Star scores for "Getting 
Needed Prescription Drugs", 
"Rating of Drug Plan", and 
"Members Choosing to 
Leave the Plan" 
Weak positive associations 
between high-risk medication 
scores and member 
experience measures; getting 
needed prescription drugs 
most highly associated with 
member ratings 
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Table 2. Sample Research Questions using SEER-CAHPS data* 
 
Patient Experience 
• How have patient experiences among older cancer patients changed over time? 
• How do the experiences of cancer patients with multiple chronic conditions compare to individuals without cancer or with no comorbidities? 
• Do cancer patient experiences predict mortality and survival? 
• How do cancer patient experiences vary across socio-demographic groups? 
• Are there regional, geographic, and/or health plan effects on cancer patient experiences of care? 
Patient/Provider Communication 
• Do cancer patient experiences with communications predict survival? 
• How do perceptions of experiences of care vary between cancer types? 
• Does higher perceived quality patient/provider communication predict different healthcare utilization patterns among cancer survivors?  
Care Coordination 
• Does perception of care coordination predict adherence to follow-up care in cancer survivors?  
• Does perception of care coordination vary based on cancer phase (post diagnosis, treatment, in last year of life)? 
• Does perception of care coordination vary by cancer treatment modality? 
Access to Care 
• Is perceived access to care associated with time between diagnosis and first course of cancer treatment? 
• Do patient experiences with care mediate the association between race/ethnicity and survival across cancer types? 
• Does type of healthcare provider seen predict perceived timeliness of care for cancer patients? 
Patient Perceptions of Care Quality 
• Do cancer patient experiences with quality predict subsequent healthcare utilization? 
• Does perceived quality of provider vary by cancer type? 
Other Aspects of Patient Experience 
• Do experiences with prescription drug plan predict adherence to cancer treatment? 
• Do experiences with getting prescription drugs predict overall survival for cancer patients? 
• Do cancer patient experiences with customer service vary across urban and rural settings? 
 
*Analyses of some of these topics may require additional linkages by investigators. In addition, availability of data to answer given research questions varies across 
cancer sites and years of diagnosis. 
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Table 3. Demographic characteristics of CAHPS respondents residing in SEER areas by program type: 1997–2013 
  
Cancer (n=205,339) Non-cancer (n=724,965) 
Demographics Total MA FFS Total MA FFS 
    N % N %   N % N % 
Total 205,339 124,668 60.7 80,671 39.3 724,965 444,740 61.3 280,225 38.7 
Age 
          
Under 65 11,222 5,811 4.7 5,411 6.7 80,087 41,947 9.4 38,140 13.6 
65–74 97,047 61,054 49.0 35,993 44.6 350,214 221,501 49.8 128,713 46.0 
75–84 75,652 45,815 36.7 29,837 37.0 224,358 140,951 31.7 83,407 29.8 
85+ 21,418 11,988 9.6 9,430 11.7 70,306 40,341 9.0 29,965 10.7 
Gender 
          
Male 101,819 61,754 49.5 40,065 49.7 297,013 180,489 40.6 116,524 41.6 
Female  103,520 62,914 50.5 40,606 50.3 427,953 264,251 59.4 163,701 58.4 
Race/ethnicity 
          
White 153,310 90,417 72.5 62,893 78.0 496,331 294,331 66.2 202,128 72.1 
Black 13,179 8,404 6.7 4,775 5.9 49,457 31,857 7.2 17,600 6.3 
Other 1,426 1,040 0.8 386 0.5 5,228 3,828 0.9 1,400 0.5 
Asian 9,343 6,461 5.2 2,882 3.6 44,013 29,675 6.7 14,338 5.1 
Hispanic 12,467 8,969 7.2 3,498 4.3 69,405 48,785 11.0 20,621 7.4 
North 
American 
Native 
674 389 0.3 285 0.4 3,323 1,718 0.4 1,605 0.6 
Mixed, 
non-
Hispanic 
3,286 1,926 1.5 1,360 1.7 13,454 1,802 1.8 5,672 2.0 
Unknown 11,654 7,062 5.7 4,592 5.7 43,734 26,872 6.0 16,862 6.0 
Education 
          
Did Not 
Complete 
High 
School 
42,345 27,152 21.8 15,193 18.8 161,102 104,420 23.5 56,682 20.2 
High 
School 
Graduate 
or GED 
60,878 37,403 30.0 23,475 29.1 214,932 132,692 29.8 82,240 29.4 
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Some 
College/2-years 
Degree 
46,722 28,856 23.1 17,866 22.1 167,215 103,200 23.2 64,015 22.8 
4-years College 
Graduate 
19,159 10,824 8.7 8,335 10.3 61,018 35,119 7.9 25,899 9.2 
More than 4-
years College 
Degree 
23,653 12,740 10.2 10,913 13.5 74,309 40,162 9.0 34,147 12.2 
Unknown 12,582 7,693 6.2 4,889 6.1 46,389 29,147 6.6 17,242 6.2 
Health 
characteristics-
smoking 
          
Non Smoker or 
Former Smoker 
171,882 103,834 83.3 68,048 84.4 608,943 374,549 84.2 234,394 83.6 
Current Smoker 21,941 13,772 11.0 8,169 10.1 74,423 44,175 9.9 30,248 10.8 
Unknown 11,516 7,062 5.7 4,454 5.5 41,599 26,016 5.9 15,583 5.6 
Spanish survey 
          
English 190,352 115,842 92.9 74,510 92.4 673,121 412,434 92.7 260,687 93.0 
Spanish 1,529 1,037 0.8 492 0.6 11,737 7,839 1.8 3,898 1.4 
None/ 
Unknown 
13,458 7,789 6.2 5,669 7.0 40,107 24,467 5.5 15,640 5.6 
Proxy status 
          
Proxy 22,086 12,244 9.8 9,842 12.2 89,418 51,399 11.6 38,019 13.6 
No Proxy 155,394 98,371 78.9 57,023 70.7 524,107 336,071 75.6 188,036 67.1 
Unknown 27,859 14,053 11.3 13,806 17.1 111,440 57,270 12.9 54,170 19.3 
General health 
status 
          
Excellent 14,040 9,093 7.3 4,947 6.1 60,697 38,833 8.7 21,864 7.8 
Very Good 48,929 30,570 24.5 18,359 22.8 180,799 122,755 25.4 68,024 24.3 
Good 74,469 46,115 37.0 28,354 35.1 248,570 156,403 35.2 92,167 32.9 
Fair 47,614 27,920 22.4 19,694 24.4 160,983 96,059 21.6 64,924 23.2 
Poor 13,252 6,694 5.4 6,558 8.1 47,258 24,143 5.4 23,115 8.3 
Unknown 7,035 4,276 3.4 2,759 3.4 26,658 16,527 3.7 10,131 3.6 
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Table 4a. Number of SEER-CAHPS respondents by first cancer site and date of diagnosis: Managed Care (no claims data available) 
 
First cancer  Total 
number 
of SEER 
linked 
patients 
First survey before 
month of first cancer 
diagnosis 
  First survey within 2 
years of first cancer 
diagnosis 
  First survey within 
3–5 years of first 
cancer diagnosis 
  First survey within 
6–10 years of first 
cancer diagnosis 
  First survey within 
11+ years of first 
cancer diagnosis 
  
N %   N %   N %   N %   N % 
Prostate 24,551 8,114 33.0 
 
4,076 16.6 
 
4,059 16.5 
 
5,165 21.0 
 
3,137 12.8 
Breast 22,668 7,110 31.4 
 
3,216 14.2 
 
2,939 13.0 
 
4,158 18.3 
 
5,245 23.1 
Colorectal 13,538 6,057 44.7 
 
1,896 14.0 
 
1,556 11.5 
 
1,903 14.1 
 
2,126 15.7 
Lung and 
Bronchial 
11,617 8,917 76.8 
 
1,331 11.5 
 
567 4.9 
 
467 4.0 
 
335 2.9 
Ovary 1,414 686 48.5 
 
174 12.3 
 
109 7.7 
 
142 10.0 
 
303 21.4 
Uterine 
Corpus 
3,901 1,037 26.6 
 
463 11.9 
 
431 11.0 
 
653 16.7 
 
1,317 33.8 
Uterine Cervix 1,583 128 8.1 
 
30 1.9 
 
67 4.2 
 
134 8.5 
 
1,224 77.3 
Bladder 6,298 3,037 48.2 
 
915 14.5 
 
717 11.4 
 
804 12.8 
 
825 13.1 
Melanoma 6,962 2,863 41.1 
 
990 14.2 
 
946 13.6 
 
1,034 14.9 
 
1,129 16.2 
Head and 
Neck 
6,358 2,954 46.5 
 
883 13.9 
 
727 11.4 
 
801 12.6 
 
993 15.6 
Kidney and 
Renal Pelvis 
2,877 1,427 49.6 
 
417 14.5 
 
364 12.7 
 
350 12.2 
 
319 11.1 
Non-Hodgkin 
Lymphomas 
4,271 2,294 53.7 
 
580 13.6 
 
474 11.1 
 
492 11.5 
 
431 10.1 
Leukemia 2,379 1,497 62.9 
 
303 12.7 
 
215 9.0 
 
211 8.9 
 
153 6.4 
Stomach 1,414 931 65.8 
 
196 13.9 
 
81 5.7 
 
101 7.1 
 
105 7.4 
Esophagus 739 561 75.9 
 
80 10.8 
 
48 6.5 
 
33 4.5 
 
17 2.3 
Pancreas 2,019 1,835 90.9 
 
112 5.5 
 
35 1.7 
 
20 1.0 
 
17 0.8 
Liver and 
Intrahepatic 
Bile Duct 
924 768 83.1 
 
91 9.8 
 
38 4.1 
 
19 2.1 
 
8 0.9 
Simultaneous 
cancers* 
1,758 1,004 57.1 
 
232 13.2 
 
161 9.2 
 
193 11.0 
 
168 9.6 
Other 9,397 5,907 62.9   1,141 12.1   781 8.3   739 7.9   829 8.8 
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Table 4b. Number of SEER-CAHPS respondents by first cancer site and date of diagnosis: Fee-for-Service (claims data available) 
 
  Total number 
of SEER 
linked patients 
First survey before 
month of first cancer 
diagnosis 
First survey within 2 
years of first cancer 
diagnosis 
First survey within 3–
5 years of first cancer 
diagnosis 
First survey within 6–
10 years of first 
cancer diagnosis 
First survey within 
11+ years of first 
cancer diagnosis 
  
N % N % N % N % N % 
Prostate 16,464 3,746 22.8 2,795 17.0 3,078 18.7 4,103 24.9 2,742 16.7 
Breast 15,440 3,429 22.2 2,104 13.6 2,457 15.9 3,349 21.7 4,101 26.6 
Colorectal 8,195 2,543 31.0 1,350 16.5 1,237 15.1 1,532 18.7 1,533 18.7 
Lung and 
Bronchial 
6,420 4,142 64.5 992 15.5 550 8.6 474 7.4 262 4.1 
Ovary 919 307 33.4 138 15.0 108 11.8 134 14.6 232 25.2 
Uterine Corpus 2,753 540 19.6 349 12.7 346 12.6 526 19.1 992 36.0 
Uterine Cervix 1,020 56 5.5 32 3.1 36 3.5 85 8.3 811 79.5 
Bladder 3,992 1,363 34.1 680 17.0 628 15.7 706 17.7 615 15.4 
Melanoma 5,134 1,371 26.7 848 16.5 854 16.6 1,009 19.7 1,052 20.5 
Head and Neck 4,530 1,600 35.3 713 15.7 717 15.8 717 15.8 783 17.3 
Kidney and 
Renal Pelvis 
1,964 745 37.9 330 16.8 290 14.8 347 17.7 252 12.8 
Non-Hodgkin 
Lymphomas 
2,773 1,030 37.1 470 16.9 444 16.0 468 16.9 361 13.0 
Leukemia 1,596 714 44.7 253 15.9 214 13.4 253 15.9 162 10.2 
Stomach 759 415 54.7 111 14.6 74 9.7 95 12.5 64 8.4 
Esophagus 420 261 62.1 65 15.5 36 8.6 36 8.6 22 5.2 
Pancreas 1,007 828 82.2 107 10.6 34 3.4 23 2.3 15 1.5 
Liver and 
Intrahepatic Bile 
Duct 
470 337 71.7 64 13.6 39 8.3 22 4.7 - - 
Simultaneous 
cancers* 
1,078 436 40.4 198 18.4 156 14.5 161 14.9 127 11.8 
Other 5,737 2,734 47.7 904 15.8 726 12.7 690 12.0 683 11.9 
 
 
 
